Cargando…
Therapeutic Differentiation of Tumor-derived Insulin-producing Cells Selected for Resistance to Diabetogenic Drugs
Differentiation therapy has been proposed as a new approach to selectively engage the process of tumor cell differentiation during chemotherapy of cancer. Our recent in vitro study suggests that such an approach can be extended and utilized for the selection of tumor-derived insulin-producing cells...
Autores principales: | Bloch, Konstantin, Vardi, Pnina |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2477727/ https://www.ncbi.nlm.nih.gov/pubmed/11467414 http://dx.doi.org/10.1155/EDR.2000.233 |
Ejemplares similares
-
Streptozotocin and Alloxan-based Selection Improves Toxin Resistance of Insulin-Producing RINm Cells
por: Bloch, Konstantin O., et al.
Publicado: (2000) -
Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice
por: Lorza-Gil, Estela, et al.
Publicado: (2019) -
Diabetogene Umweltfaktoren
por: Wabnitz, Katharina, et al.
Publicado: (2022) -
Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020) -
Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects
por: Li, Zhiwei, et al.
Publicado: (2015)